Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen B Fox

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomasStephen B Fox, Philip Brown, Cheng Han, et al.
Breast Cancer Research : BCR|June 17, 2015
Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastJia-Min B Pang, Kylie L Gorringe, Stephen Q Wong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Comparison of Four PD-L1 Immunohistochemical Assays in Lung CancerShona Hendry, David J Byrne, Gavin M Wright, et al.
Breast Cancer Research and Treatment|October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosisCecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
Frontiers in Oncology|November 22, 2021
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?Victoria Bouchè, Giovanni Aldegheri, Carmine Antonio Donofrio, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2025
Validation of the SOPHiA DDM HRD Solution as a Companion Diagnostic for PARPi Access in AustraliaAndrew P Fellowes, David Y H Choong, Christopher R McEvoy, et al.
Breast Cancer Research and Treatment|June 22, 2010
DNA methylation profiling of phyllodes and fibroadenoma tumours of the breastKatie T Huang, Alexander Dobrovic, Max Yan, et al.
Cancer Research|September 3, 2004
CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alphaStephen B Fox, José Bragança, Helen Turley, et al.
The Journal of Pathology|March 3, 2004
Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleusStephen B Fox, Helen Turley, Michelle Cheale, et al.
Breast Cancer Research and Treatment|November 21, 2007
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomasGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomasStephen B Fox, Philip Brown, Cheng Han, et al.
Breast Cancer Research : BCR|June 17, 2015
Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastJia-Min B Pang, Kylie L Gorringe, Stephen Q Wong, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 28, 2017
Comparison of Four PD-L1 Immunohistochemical Assays in Lung CancerShona Hendry, David J Byrne, Gavin M Wright, et al.
Breast Cancer Research and Treatment|October 24, 2003
The presence of a fibrotic focus in invasive breast carcinoma correlates with the expression of carbonic anhydrase IX and is a marker of hypoxia and poor prognosisCecile G Colpaert, Peter B Vermeulen, Stephen B Fox, et al.
Frontiers in Oncology|November 22, 2021
BRAF Signaling Inhibition in Glioblastoma: Which Clinical Perspectives?Victoria Bouchè, Giovanni Aldegheri, Carmine Antonio Donofrio, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2025
Validation of the SOPHiA DDM HRD Solution as a Companion Diagnostic for PARPi Access in AustraliaAndrew P Fellowes, David Y H Choong, Christopher R McEvoy, et al.
Breast Cancer Research and Treatment|June 22, 2010
DNA methylation profiling of phyllodes and fibroadenoma tumours of the breastKatie T Huang, Alexander Dobrovic, Max Yan, et al.
Cancer Research|September 3, 2004
CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alphaStephen B Fox, José Bragança, Helen Turley, et al.
The Journal of Pathology|March 3, 2004
Phosphorylated KDR is expressed in the neoplastic and stromal elements of human renal tumours and shuttles from cell membrane to nucleusStephen B Fox, Helen Turley, Michelle Cheale, et al.
Breast Cancer Research and Treatment|November 21, 2007
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomasGaynor J Bates, Stephen B Fox, Cheng Han, et al.
Pageof 26